Etana Biotechnologies is dedicated to producing high-quality, affordable biopharmaceutical products aimed at treating various serious medical conditions, including metabolic disorders, autoimmune diseases, and cancer. Established in 2014, the company adheres to stringent cGMP (current Good Manufacturing Practices) guidelines, ensuring compliance with global regulatory standards. This commitment to quality is reflected in their world-class manufacturing facilities, which are designed to meet both domestic and international market needs. Etana's workforce comprises top graduates from leading Indonesian universities in fields such as pharmacy, chemical engineering, and medicine, fostering a culture that prioritizes innovation and patient care.

The company's product pipeline includes promising therapies such as RENOGEN® (epoetin alfa), which is intended to improve the quality of life for patients undergoing dialysis by maintaining red blood cell levels and reducing the need for transfusions. Additionally, Etana plans to produce BEVAGEN® (Bevacizumab biosimilar), a critical treatment for advanced non-small cell lung cancer and metastatic colorectal cancer, in collaboration with Innovent Biologics. Looking ahead, Etana aims to become a pioneer in the manufacture of monoclonal antibody drugs (MABs), which are designed to enhance the immune system's ability to combat cancer with fewer side effects compared to traditional chemotherapy. Through these innovative products, Etana is committed to making significant contributions to the healthcare landscape in Indonesia.

Indonesia

Etana Biotechnologies is an Indonesia-based biotechnology company that was founded in 2015. The company is in the business of manufacturing PIC/S standard and marketing high-quality and affordable biosimilars for the Indonesian market. Etana Biotechnologies has also secured funding for its oncology pipeline and has received investments from Chinese VCs, Innovent Biologics Inc., and China Medical System Holdings Ltd.

Etana Biotechnologies

Company Details